Methotrexate (Accord Healthcare, Inc.)
Welcome to the PulseAid listing for the Methotrexate drug offered from Accord Healthcare, Inc.. This Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Accord Healthcare, Inc. |
NON-PROPRIETARY NAME: | Methotrexate |
SUBSTANCE NAME: | METHOTREXATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
ROUTE: | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-02-01 |
END MARKETING DATE: | 0000-00-00 |
Methotrexate HUMAN PRESCRIPTION DRUG Details:
Item Description | Methotrexate from Accord Healthcare, Inc. |
LABELER NAME: | Accord Healthcare, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/mL) |
START MARKETING DATE: | 2014-02-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16729-277_ffb66c4a-52b1-4088-9a69-2a2cf2437a1c |
PRODUCT NDC: | 16729-277 |
APPLICATION NUMBER: | ANDA040716 |
Other METHOTREXATE Pharmaceutical Manufacturers / Labelers: